| Registered Number:12403147 |
For the year ended 31 January 2025
England and Wales
Unaudited Financial Statements
For the year ended 31 January 2025
Route1 Pharma Limited
Contents Page
1
Statement of Financial Position
2 to 4
Notes to the Financial Statements
Route1 Pharma Limited
Statement of Financial Position
2024
2025
| Property, plant and equipment |
912,360
874,365
2
912,360
874,365
127,000
100,000
3
| Trade and other receivables |
43,316
34,052
4
111,789
| Cash and cash equivalents |
88,996
223,048
282,105
| Trade and other payables: amounts falling due within one |
| year |
(260,572)
(250,172)
5
21,533
(27,124)
Net current liabilities
| Total assets less current liabilities |
885,236
895,898
| Trade and other payables: amounts falling due after more |
| than one year |
(614,800)
(430,746)
6
454,490
Net assets
281,098
2
2
454,488
281,096
454,490
281,098
Shareholders' funds
| For the year ended 31 January 2025 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies. |
| The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2025 in accordance with Section 476 of the Companies Act 2006 |
| The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each |
| financial year and of its profit or loss for each financial year in accordance with the requirements of Section 394 and 395 and |
| which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as |
| applicable to the company. |
| In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
| The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. |
| Miss Puneeta Joshi Director |
| These financial statements were approved and authorised for issue by the Board on 12 February 2025 and were signed by: |
| The notes form part of these financial statements |
1 of 4
For the year ended 31 January 2025
Route1 Pharma Limited
Notes to the Financial Statements
Statutory Information
| Route1 Pharma Limited is a private limited company, limited by shares, domiciled in England and Wales, registration number |
| 12403147. |
46A Dukes Wood Avenue
Buckinghamshire
Gerrards Cross
England
SL9 7JU
| The presentation currency is £ sterling. |
Basis of preparing the financial statements
| These financial statements have been prepared in accordance with the provisions of Section 1A of Financial Reporting Standard |
| 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The |
| financial statements have been prepared under the historical costs convention as modified by the revaluation of certain assets. |
Revenue recognition
| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax or other similar sales taxes. |
Property, plant and equipment
| Property, plant and equipment, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis: |
Plant and Machinery
Investment property
| Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss. |
Inventories
| Inventories are value at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items. |
Pension costs and other post-retirement benefits
| The company operates a defined contribution pension scheme for the benefit of its directors/and employees. Contributions payable are charged to the profit and loss account in the period in which they are payable. |
2 of 4
For the year ended 31 January 2025
Route1 Pharma Limited
Notes to the Financial Statements Continued
| 2. Property, plant and equipment |
901,908
81,908
820,000
46,150
46,150
-
820,000
128,058
948,058
| Provision for depreciation and impairment |
27,543
27,543
-
Charge for year
8,155
8,155
-
35,698
35,698
-
820,000
92,360
912,360
820,000
54,365
874,365
2024
2025
100,000
127,000
| 4. Trade and other receivables |
2024
2025
34,052
43,316
| 5. Trade and other payables: amounts falling due within one year |
2024
2025
| Taxation and social security |
77,184
67,644
172,988
192,928
250,172
260,572
3 of 4
For the year ended 31 January 2025
Route1 Pharma Limited
Notes to the Financial Statements Continued
| 6. Trade and other payables: amounts falling due after more than one year |
2024
2025
430,746
614,800
| 7. Average number of persons employed |
During the year the average number of employees was 14 (2024 : 15)
4 of 4